Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Research

• Publication date

  2006-04-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-05-4032PMID 16618782
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polymorphisms associated with asthma are inversely related to glioblastoma multiforme.

  2006cited by this paper
• Polymorphisms associated with asthma are inversely related to glioblastoma multiforme.

  2006cited by this paper
• Diagnostic, treatment, and demographic factors influencing survival in a population-based study of adult glioma patients in the San Francisco Bay Area.

  2006cited by this paper
• ERCC2 /XPD gene polymorphisms and lung cancer: a HuGE review.

  2005cited by this paper
• History of chickenpox and shingles and prevalence of antibodies to varicella-zoster virus and three other herpesviruses among adults with glioma and controls.

  2005cited by this paper
• ERCC1 Codon 118 Polymorphism Is a Predictive Factor for the Tumor Response to Oxaliplatin/5-Fluorouracil Combination Chemotherapy in Patients with Advanced Colorectal Cancer

  2005cited by this paper
• Years of life lost (YLL) from cancer is an important measure of population burden – and should be considered when allocating research funds

  2005cited by this paper
• The involvement of key DNA repair pathways in the formation of chromosome rearrangements in embryonic stem cells.

  2005cited by this paper
• Molecular Features of Adult Glioma Associated with Patient Race/Ethnicity, Age, and a Polymorphism in O6-Methylguanine-DNA-Methyltransferase

  2005cited by this paper
• The molecular epidemiology of gliomas in adults.

  2005cited by this paper
• ERCC1 and ERCC2 polymorphisms and adult glioma.

  2005influential reference
• Immunotherapy for human glioma: innovative approaches and recent results

  2005cited by this paper
• Positive and Negative Associations of Human Leukocyte Antigen Variants with the Onset and Prognosis of Adult Glioblastoma Multiforme

  2005cited by this paper
• The C3435T Polymorphism of MDR1 and Susceptibility to Adult Glioma

  2005cited by this paper
• Current status of therapy of solid tumors: brain tumor therapy.

  2005cited by this paper
• Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma.

  2005cited by this paper
• Polymorphisms in GLTSCR1 and ERCC2 are associated with the development of oligodendrogliomas

  2005cited by this paper
• ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer.

  2005cited by this paper
• Dendritic cell vaccines and immunity in glioma patients.

  2005cited by this paper
• Gene expression profiling and genetic markers in glioblastoma survival.

  2005cited by this paper
• ERCC1 and Clinical Resistance to Platinum-Based Therapy

  2005cited by this paper
• Polymorphisms in ERCC1 and Grade 3 or 4 Toxicity in Non–Small Cell Lung Cancer Patients

  2005cited by this paper
• Immunotherapy for malignant glioma: current approaches and future directions

  2005cited by this paper
• Chemoresistance in non-small cell lung cancer.

  2005cited by this paper
• Glutathione-S-transferase variants and adult glioma.

  2004influential reference
• Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis.

  2004cited by this paper
• Glutathione S-Transferase Polymorphisms and Survival in Primary Malignant Glioma

  2004influential reference
• Genetic Pathways to Glioblastoma

  2004cited by this paper
• Gene Expression Profiling of Gliomas Strongly Predicts Survival

  2004cited by this paper
• An Epidermal Growth Factor Receptor Intron 1 Polymorphism Mediates Response to Epidermal Growth Factor Receptor Inhibitors

  2004cited by this paper
• Allelic length of a CA dinucleotide repeat in the egfr gene correlates with the frequency of amplifications of this sequence—first results of an inter‐ethnic breast cancer study

  2004cited by this paper
• Reduced Immunoglobulin E and Allergy among Adults with Glioma Compared with Controls

  2004cited by this paper
• Excision Repair Cross-Complementation Group 1 Polymorphism Predicts Overall Survival in Advanced Non-Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy

  2004cited by this paper
• A Functional Polymorphism in the EGF Gene Is Found with Increased Frequency in Glioblastoma Multiforme Patients and Is Associated with More Aggressive Disease

  2004cited by this paper
• The Structure-Specific Endonuclease Ercc1-Xpf Is Required To Resolve DNA Interstrand Cross-Link-Induced Double-Strand Breaks

  2004cited by this paper
• Molecular predictors of response to chemotherapy in lung cancer.

  2004cited by this paper
• Multiple Protein-Protein Interactions by RNA Polymerase I-Associated Factor PAF49 and Role of PAF49 in rRNA Transcription

  2004cited by this paper
• Common gene polymorphisms, cancer progression and prognosis.

  2004cited by this paper
• Age-Dependent Prognostic Effects of Genetic Alterations in Glioblastoma

  2004cited by this paper
• Comparative genomic hybridization analysis of astrocytomas: prognostic and diagnostic implications.

  2004cited by this paper
• New targeted therapies in breast cancer.

  2004cited by this paper
• Advances in the biology and treatment of oligodendrogliomas

  2004cited by this paper
• Advances in the biology and treatment of oligodendrogliomas.

  2004cited by this paper
• Grade II astrocytomas are subgrouped by chromosome aberrations.

  2003cited by this paper
• Epidermal Growth Factor and Ionizing Radiation Up-regulate the DNA Repair Genes XRCC1 and ERCC1 in DU145 and LNCaP Prostate Carcinoma through MAPK Signaling

  2003cited by this paper
• Pharmacogenetics in cancer treatment.

  2003cited by this paper
• V75R576 IL-4 Receptor α Is Associated with Allergic Asthma and Enhanced IL-4 Receptor Function1

  2002cited by this paper
• All in the head: obstacles for immune rejection of brain tumours

  2002cited by this paper
• Association of IL4R haplotypes with type 1 diabetes.

  2002cited by this paper
• V75R576 IL-4 receptor alpha is associated with allergic asthma and enhanced IL-4 receptor function.

  2002cited by this paper
• Role of CD23 in astrocytes inflammatory reaction during HIV-1 related encephalitis.

  2001cited by this paper
• Glioblastoma Patients Epidermal Growth Factor Receptor , and Survival in Analysis of Complex Relationships between Age , p 53 , Updated

  2001cited by this paper
• PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

  2001cited by this paper
• EGFR overexpression and radiation response in glioblastoma multiforme.

  2001cited by this paper
• Definition of human interleukin-4 receptor alpha chain haplotypes and allelic association with atopy markers.

  1999cited by this paper
• FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces, In Vitro, Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells

  1999cited by this paper
• CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation?

  1999cited by this paper
• FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.

  1999cited by this paper
• Chromosomal abnormalities in glioblastoma multiforme by comparative genomic hybridization: correlation with radiation treatment outcome.

  1999cited by this paper
• Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma.

  1999cited by this paper
• The low-affinity receptor for IgE (Fc epsilon RII or CD23) as a therapeutic target.

  1997cited by this paper
• The low-affinity receptor for IgE (FcεRII or CD23) as a therapeutic target

  1997cited by this paper
• ERCC1/ERCC4 5'-endonuclease activity as a determinant of hypoxic cell radiosensitivity.

  1996cited by this paper
• Categorical Data Analysis Using The SAS1 System

  1995cited by this paper
• Structure and function of the low affinity IgE receptor.

  1994cited by this paper
• The New WHO Classification of Brain Tumours

  1993cited by this paper
• IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature and symbolism for amino acids and peptides. Recommendations 1983.

  1984cited by this paper
• Cancer : Principles and Practice of Oncology

  1982cited by this paper
• Immunobiology of primary intracranial tumors.

  1977cited by this paper
• Neoplasms of the central nervous system.

  1977cited by this paper
• Immunobiology of primary intracranial tumors. Part 1: studies of the cellular and humoral general immune competence of brain-tumor patients.

  1977cited by this paper
• International Union of Pure and Applied Chemistry and International Union of Biochemistry Joint Commission on Biochemical Nomenclature* Nomenclature and Symbolism for Amino Acids and Peptides Nomenclature Committee of Iub (nc—iub) (those Additional to Jcbn): Nomenclature and Symbolism for Amino. Aci

  year unknowncited by this paper
• For Personal Use Only. Reproduce with Permission from the Lancet Publishing Group. Genetic Resistance Factor for Hiv-1 and Immune Response to Varicella Zoster Virus

  year unknowncited by this paper

• AllergoOncology in Review: Harnessing Allergy in the Field of Oncology to Improve Patient Outcomes.

  2026cites this paper
• Association of immunoglobulin E levels with glioma risk and survival

  2024cites this paper
• AllergoOncology: Biomarkers and refined classification for research in the allergy and glioma nexus—A joint EAACI‐EANO position paper

  2024cites this paper
• The Signaling of Neuregulin-Epidermal Growth Factor Receptors and Its Impact on the Nervous System

  2023cites this paper
• Antibodies to varicella-zoster virus and three other herpesviruses and survival in adults with glioma.

  2023cites this paper
• Allergic airway inflammation delays glioblastoma progression and reinvigorates systemic and local immunity in mice

  2022cites this paper
• B-Lymphocytes in the Pathophysiology of Pancreatic Adenocarcinoma

  2022cites this paper
• Relationship between low serum IgE levels and malignancies in 9/11 World Trade Center responders.

  2022cites this paper
• An analysis of eosinophil and basophil based indices in patients with glioblastoma and their correlation with survival.

  2022cites this paper
• Is There a Clinical Significance of Very Low Serum Immunoglobulin E Level?

  2021cites this paper
• Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments

  2021cites this paper
• Prognostic value of pretreatment circulating basophils in patients with glioblastoma

  2021cites this paper
• Is There a Clinical Signi � cance of Very Low Serum Immunoglobulin E Level ?

  2021cites this paper
• The other side of the coin: IgE deficiency, a susceptibility factor for malignancy occurrence

  2021cites this paper
• Improved survival in several cancers with use of H1-antihistamines desloratadine and loratadine.

  2021cites this paper
• Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma

  2020cites this paper
• Allergies and Cancers

  2020cites this paper
• Eosinophil and lymphocyte counts predict bevacizumab response and survival in recurrent glioblastoma

  2020cites this paper
• Systems Immunology Approach in Understanding the Association of Allergy and Cancer

  2020cites this paper
• AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer—a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)

  2020cites this paper
• Glioblastoma: Is There Any Blood Biomarker with True Clinical Relevance?

  2020cites this paper
• Increased Malignancy Rate in Children With IgE Deficiency: A Single-center Experience.

  2020cites this paper
• Improved cancer survival with use of common antihistamines

  2020cites this paper
• The Significant of miR-196a2 C>T Single Nucleotide Polymorphism and Serum Levels of Interleukin-1β (IL-1β) and Intrleukin-6 (IL-6) in Colorectal Cancer

  2019cites this paper
• Comparison and analysis of lncRNA-mediated ceRNA regulation in different molecular subtypes of glioblastoma.

  2019cites this paper
• GOLGA7 rs11337, a Polymorphism at the MicroRNA Binding Site, Is Associated with Glioma Prognosis

  2019cites this paper
• Molecular Biomarkers of Brain and Spinal Cord Astrocytomas

  2019cites this paper
• Allergy may confer better survival on patients with gliomas.

  2019cites this paper
• Serially measured pre-diagnostic levels of serum cytokines and risk of brain cancer in active component military personnel

  2018cites this paper
• Origin of Gliomas

  2018cites this paper
• EGFR as a clinical marker in glioblastomas and other gliomas

  2018cites this paper
• A case-control study of the association between the EGFR gene and glioma risk in a Chinese Han population

  2017cites this paper
• Correlations of Galectin-3 Gene Polymorphisms with Risk and Prognosis of Cervical Cancer in Chinese Populations: A Case-Control Study

  2017cites this paper
• Identification of cell surface markers from multidimensional microarray data utilizing spherical Self Organizing Maps

  2016cites this paper
• Pro- and anti-tumour effects of B cells and antibodies in cancer: a comparison of clinical studies and preclinical models

  2016cites this paper
• The relationship between polymorphisms of XRCC5 genes with astrocytoma prognosis in the Han Chinese population

  2016cites this paper
• A Unique Procedure to Identify Cell Surface Markers Through a Spherical Self-Organizing Map Applied to DNA Microarray Analysis

  2016cites this paper
• Malignant gliomas: old and new systemic treatment approaches

  2016cites this paper
• Polymorphism in the IL4R gene and clinical features are associated with glioma prognosis

  2016cites this paper
• Single Nucleotide Polymorphisms in IL-10, IL-12p40, and IL-13 Genes and Susceptibility to Glioma

  2015cites this paper
• Survival and low-grade glioma: the emergence of genetic information.

  2015cites this paper
• Significant Association of Proline Allele in Tp53 Gene, Arg72pro Polymorphism in Brain Tumors and its Prognostic Value

  2015cites this paper
• A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools.

  2015cites this paper
• Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas

  2014cites this paper
• Towards developing biomarkers for glioblastoma multiforme: a proteomics view

  2014cites this paper
• Association between the Epidermal Growth Factor +61G/A Polymorphism and Glioma Risk: A Meta-Analysis

  2014cites this paper
• Impact of Single Nucleotide Polymorphism in IL-4, IL-4R Genes and Systemic Concentration of IL-4 on the Incidence of Glioma in Iraqi Patients

  2014cites this paper
• Immunotherapy advances for glioblastoma.

  2014cites this paper
• Genetic regulation of immunoglobulin E level in different pathological states: integration of mouse and human genetics

  2014cites this paper
• A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Recurrent Glioblastoma Multiforme: Final Report (Protocol BT-21)

  2014cites this paper
• [Gene disorders and molecular genetic subtypes of malignant gliomas].

  2013influential citation
• Response of glioblastoma cells to doxorubicin and methotrexate : role of methamphetamine

  2013cites this paper
• Natural History and Spontaneous Prognostic Factors

  2013cites this paper
• Epidemiological associations of allergy, IgE and cancer

  2013cites this paper
• Studies on the Roles of PDGFRA and EGFR in the Classification and Identification of Therapeutic Targets for Human Gliomas

  2013cites this paper
• Anti-human-cytomegalovirus immunoglobulin G levels in glioma risk and prognosis

  2013cites this paper
• Risk factors for gliomas. An extensive review

  2013cites this paper
• RI εIgE Adjuvanticity: Key Role of Fc

  2013cites this paper
• Integration of epidemiology, immunobiology, and translational research for brain tumors

  2013cites this paper
• Tissue and Plasma Thioredoxin Reductase Expressions in Patients with Glioblastoma Multiforme

  2013cites this paper
• Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12.

  2012cites this paper
• Changes of the chicken chorioallantoic membrane and the behaviour of transplanted glioblastoma

  2012cites this paper
• Word Count : 3425 Number of Tables : 3 Number of Figures : 3 Statement of Translational Relevance : Glioblastoma

  2012cites this paper
• Lower incidence of biliary carcinoma in patients with primary sclerosing cholangitis and high serum levels of immunoglobulin E.

  2012cites this paper
• Genetics of adult glioma.

  2012cites this paper
• Identification of blood protein biomarkers that aid in the clinical assessment of patients with malignant glioma.

  2012cites this paper
• Prognostic Significance of EGFR Gene Amplification and Overexpression in Diffuse Astrocytomas—A Literature Study

  2012influential citation
• Epidemiology: allergy history, IgE, and cancer

  2012cites this paper
• Eosinophils in glioblastoma biology

  2012cites this paper
• IDH1/2 (isocitrate dehydrogenase 1/2) Mutations in Gliomas : genotype-Phenotype Correlation, Prognostic impact, and Response to Irradiation

  2012cites this paper
• Risk and prognostic factors for malignant glioma

  2012cites this paper
• IgE and chemotherapy

  2012cites this paper
• 2 Variants Are Associatedwith Survival in Glioblastoma Patients

  2012cites this paper
• SSBP2 Variants Are Associated with Survival in Glioblastoma Patients

  2012cites this paper
• Epidemiology and Risk Factors

  2011cites this paper
• Translational Medicine and Reliability of Single-Nucleotide Polymorphism Studies: Can We Believe in SNP Reports or Not?

  2011cites this paper
• A Novel Approach to Exploring Potential Interactions among Single-Nucleotide Polymorphisms of Inflammation Genes in Gliomagenesis: An Exploratory Case-Only Study

  2011cites this paper
• Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking.

  2011cites this paper
• Immunotherapy of Brain Cancers: The Past, the Present, and Future Directions

  2011cites this paper
• COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells.

  2011cites this paper
• Allergy and risk of glioma: a meta‐analysis

  2011cites this paper
• Soluble IgE receptors--elements of the IgE network.

  2011cites this paper
• Therapeutics , Targets , and Chemical Biology COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells

  2011cites this paper
• Increase of plasma IgE during treatment correlates with better outcome of patients with glioblastoma.

  2011cites this paper
• Glioblastoma multiforme : is there an efficacious treatment for this lethal disease? Comparing the classic treatment protocol to two new treatment modalities

  2011cites this paper
• The Paradoxical Brain: Index

  2011cites this paper
• Selected human leukocyte antigen class II polymorphisms and risk of adult glioma.

  2011cites this paper
• Epidemiological Evidence: IgE, Atopy, and Solid Tumors

  2010cites this paper
• The mitochondrial translocator protein in human gliomas.

  2010cites this paper
• DIFFERENTIAL INVOLVEMENT OF S AND L ISOFORMS OF THE CENTROSOMAL MARK4 KINASE IN GLIOMA INITIATION AND PROGRESSION

  2010cites this paper
• 2 - Recent Advances in Epidemiology of Brain Tumors

  2010cites this paper
• Genetic variations in EGF and EGFR and glioblastoma outcome

  2010cites this paper
• Interaction between 5 genetic variants and allergy in glioma risk.

  2010cites this paper
• Daily intake of antioxidants in relation to survival among adult patients diagnosed with malignant glioma

  2010cites this paper
• Inherited variation in immune genes and pathways and glioblastoma risk

  2010cites this paper
• Role of Type 1 IFNs in Antiglioma Immunosurveillance—Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans

  2010cites this paper
• Genetic variants in inflammation pathway genes and asthma in glioma susceptibility.

  2010cites this paper
• Allergies, obesity, other risk factors and survival from pancreatic cancer

  2010cites this paper
• Antitumor IgE Adjuvanticity: Key Role of Fc

  2009cites this paper
• IgE, allergy, and risk of glioma: Update from the San Francisco Bay Area Adult Glioma Study in the Temozolomide era

  2009cites this paper